Cassaday & Co Wealth Management’s Tesla TSLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Buy
6,393
+45
+0.7% +$18.5K 0.05% 77
2025
Q4
$2.85M Sell
6,348
-5,176
-45% -$2.29M 0.06% 69
2025
Q3
$5.12M Sell
11,524
-769
-6% -$267K 0.12% 44
2025
Q2
$3.9M Buy
12,293
+461
+4% +$139K 0.1% 51
2025
Q1
$3.07M Sell
11,832
-1,044
-8% -$348K 0.09% 52
2024
Q4
$5.2M Sell
12,876
-876
-6% -$282K 0.14% 36
2024
Q3
$3.6M Buy
13,752
+79
+0.6% +$18K 0.1% 43
2024
Q2
$2.71M Sell
13,673
-108
-0.8% -$18.9K 0.09% 51
2024
Q1
$2.42M Buy
13,781
+239
+2% +$46.7K 0.08% 55
2023
Q4
$3.37M Sell
13,542
-711
-5% -$169K 0.12% 41
2023
Q3
$3.57M Buy
14,253
+964
+7% +$248K 0.15% 34
2023
Q2
$3.48M Buy
13,289
+160
+1% +$32K 0.14% 35
2023
Q1
$2.72M Buy
13,129
+81
+0.6% +$14.1K 0.12% 41
2022
Q4
$1.61M Buy
+13,048
New +$2.47M 0.07% 61

Other funds holding TSLA

Cassaday & Co Wealth Management's TSLA Position: Q1 2026 in Review

Cassaday & Co Wealth Management increased its Tesla (TSLA) stake by 0.71% in Q1 2026, buying an estimated $18.5K and bringing the position to 6,393 shares worth $2.38M. The position accounts for 0.05% of the portfolio, ranked #77.

Cassaday & Co Wealth Management first reported a position in TSLA in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.2M in Q4 2024. 4,175 funds tracked by Wall St. Rank hold TSLA as of Q1 2026.

  • Cassaday & Co Wealth Management held 6,393 shares of Tesla worth $2.38M as of Q1 2026.
  • Cassaday & Co Wealth Management bought 45 Tesla shares in Q1 2026, an estimated $18.5K.
  • Tesla made up 0.05% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #77 holding.
  • Cassaday & Co Wealth Management first reported a position in Tesla in Q4 2022 and has held it in 14 quarters since.
  • Cassaday & Co Wealth Management's Tesla position peaked at $5.2M in Q4 2024.
  • 4,175 funds tracked by Wall St. Rank held Tesla as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.